GlassScriptPhysician profile
Sumy M Michael
NPI 1427200831
$1,247.26
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $913 · 2022: $335.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $370.18 | 2021-2022 | |
| Glaxosmithkline, LLC. | $125.00 | 2021 | |
| Abiomed | $125.00 | 2021 | |
| La Jolla Pharmaceutical Company | $122.71 | 2021 | |
| Celgene Corporation | $120.85 | 2021 | |
| Alexion Pharmaceuticals, INC. | $113.21 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.20 | 2022 | |
| Amgen INC. | $92.44 | 2021 | |
| Philips North America LLC | $76.67 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumy Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.